May 17, 2022 02:54 pm
Original Link: https://www.theverge.com/2022/5/17/23094214/cerebral-halts-prescriptions-adderall
Telehealth startup Cerebralhalts controlled substance prescriptions
Mental health startup Cerebral will no longer prescribe most controlled substances, The Wall Street Journal reported.
The embattled company is facing investigations from the US Department of Justice and the Drug Enforcement Administration over its prescribing practices, which, until this week, included offering prescriptions for stimulants like Adderall.
Company co-founder Kyle Robertson wrote in an email reviewed by The Wall Street Journal that it would stop prescribing most controlled substances to new customers on Friday and transition existing patients off of the drug or out of its care by October. Cerebral will still offer drugs that treat opioid-use disorder, like Suboxone.
Robertson said in the email that the company only started...
Original Link: https://www.theverge.com/2022/5/17/23094214/cerebral-halts-prescriptions-adderall
Share this article:
Tweet
View Full Article
The Verge
The Verge is an ambitious multimedia effort founded in 2011More About this Source Visit The Verge